Visseren FLJ - Search Results

1

Long-term lifestyle change and risk of mortality and Type 2 diabetes in patients with cardiovascular disease.

Bonekamp NE, Visseren FLJ, Cramer MJ, Dorresteijn JAN, van der Meer MG, Ruigrok YM, van Sloten TT, Teraa M, Geleijnse JM, Koopal C. Bonekamp NE, et al. Among authors: visseren flj. Eur J Prev Cardiol. 2024 Jan 25;31(2):205-213. doi: 10.1093/eurjpc/zwad316. Eur J Prev Cardiol. 2024. PMID: 37774501

2

Social support and change in vascular risk factors in patients with clinical manifestations of vascular diseases.

Sol BG, van der Graaf Y, Goessens BM, Visseren FL. Sol BG, et al. Eur J Cardiovasc Nurs. 2009 Jun;8(2):137-43. doi: 10.1016/j.ejcnurse.2008.10.005. Epub 2008 Dec 3. Eur J Cardiovasc Nurs. 2009. PMID: 19054719

3

Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants.

Meijs MF, Bots ML, Cramer MJ, Vonken EJ, Velthuis BK, van der Graaf Y, Visseren FL, Mali WP, Doevendans PA; SMART Study group. Meijs MF, et al. Heart. 2009 May;95(9):728-32. doi: 10.1136/hrt.2008.157727. Epub 2009 Feb 12. Heart. 2009. PMID: 19218261

4

Relation of common carotid intima-media thickness with left ventricular mass caused by shared risk factors for hypertrophy.

Meijs MF, Doevendans PA, Cramer MJ, Vonken EJ, Velthuis BK, van der Graaf Y, Visseren FL, Mali WP, Bots ML; SMART Study group. Meijs MF, et al. J Am Soc Echocardiogr. 2009 May;22(5):499-504. doi: 10.1016/j.echo.2009.01.015. Epub 2009 Mar 9. J Am Soc Echocardiogr. 2009. PMID: 19269135

5

Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.

Achterberg S, Cramer MJ, Kappelle LJ, de Borst GJ, Visseren FL, van der Graaf Y, Algra A; SMART study Group. Achterberg S, et al. Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):424-30. doi: 10.1097/HJR.0b013e3283361ce6. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20555265

6

The effect of self-efficacy on cardiovascular lifestyle.

Sol BG, van der Graaf Y, van Petersen R, Visseren FL. Sol BG, et al. Eur J Cardiovasc Nurs. 2011 Sep;10(3):180-6. doi: 10.1016/j.ejcnurse.2010.06.005. Epub 2010 Jul 31. Eur J Cardiovasc Nurs. 2011. PMID: 20674503

7

A prediction model for left ventricular mass in patients at high cardiovascular risk.

Meijs MF, Vergouwe Y, Cramer MJ, Vonken EJ, Velthuis BK, Verton DJ, van der Graaf Y, Visseren FL, Mali WP, Doevendans PA, Bots ML; SMART study group. Meijs MF, et al. Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):621-7. doi: 10.1097/HJR.0b013e328332d4bc. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20814310

8

[Obesity-related hypertension].

Dorresteijn JA, Visseren FL, van den Meiracker AH, Spiering W. Dorresteijn JA, et al. Ned Tijdschr Geneeskd. 2011;154:A1945. Ned Tijdschr Geneeskd. 2011. PMID: 21418695 Review. Dutch.

9

Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.

Westerink J, van der Graaf Y, Faber DR, Spiering W, Visseren FL; SMART study group. Westerink J, et al. Eur J Prev Cardiol. 2012 Aug;19(4):864-73. doi: 10.1177/1741826711416045. Epub 2011 Jul 1. Eur J Prev Cardiol. 2012. PMID: 21724680

10

Mechanisms linking obesity to hypertension.

Dorresteijn JA, Visseren FL, Spiering W. Dorresteijn JA, et al. Obes Rev. 2012 Jan;13(1):17-26. doi: 10.1111/j.1467-789X.2011.00914.x. Epub 2011 Aug 10. Obes Rev. 2012. PMID: 21831233 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters